
|

| |
Track this Pro and follow
their portfolio moves with tickerspy™ alerts |
 |
|
 | RA Capital Management |
| |
Performance |
|
|
|
Similar Pro Portfolios |
|
|
|
Community |
|
| |
Today:
Week:
1-month:
All-time:
|
+1.9%
+7.4%
-0.6%
+45.6%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+1.0%
+5.4%
-8.0%
+24.7%
|
Data since: Jan-1-2008 Current Portfolio: Q3 2012
|
|
|
|
|
|
|
|
|
Share this Pro on Facebook
Share this Pro on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| ACAD |
$13.27 |
+0.26 |
+2.00% |
3,774,856 |
76% |
$974.7M |
- |
925% |
-5% |
+437.2% |
$11.2M | 4.4M shares - decrease of 666.2K shares
1 Alert (1 News) - View
|
|
|
| ACHN |
$7.77 |
+0.21 |
+2.78% |
823,358 |
77% |
$750.2M |
- |
43% |
-32% |
-27.2% |
$21.9M | 2.1M shares - decrease of 1.1M shares
No Alerts/News
|
|
|
| ANAC |
$6.09 |
-0.01 |
-0.16% |
930,678 |
144% |
$246.6M |
- |
103% |
-26% |
-6.6% |
$16.7M | 2.5M shares - increase of 138.6K shares
No Alerts/News
|
|
|
| ARTC |
$34.65 |
+0.20 |
+0.58% |
160,474 |
144% |
$976.7M |
- |
42% |
-6% |
+6.0% |
$14.2M | 439.2K shares - decrease of 123.2K shares
No Alerts/News
|
|
|
| CNDO |
$9.90 |
-0.17 |
-1.69% |
322,120 |
77% |
$259.0M |
- |
148% |
-22% |
+74.0% |
$9.2M | 1.8M shares - increase of 1.9K shares
No Alerts/News
|
|
|
| DSCI |
$14.29 |
-0.06 |
-0.42% |
35,765 |
68% |
$236.1M |
- |
62% |
-4% |
+33.3% |
$13.0M | 1.3M shares - No Change
No Alerts/News
|
|
|
| DYAX |
$2.54 |
+0.05 |
+2.01% |
420,622 |
44% |
$253.9M |
- |
66% |
-44% |
-4.5% |
$22.2M | 8.5M shares - No Change
No Alerts/News
|
|
|
| INSM |
$10.90 |
+0.34 |
+3.22% |
440,262 |
157% |
$344.1M |
- |
305% |
-3% |
+134.7% |
$11.2M | 2.5M shares - New Holding
No Alerts/News
|
|
|
| NVAX |
$2.01 |
-0.05 |
-2.43% |
1,192,194 |
67% |
$304.0M |
- |
79% |
-27% |
-15.9% |
$28.5M | 13.2M shares - No Change
No Alerts/News
|
|
|
| OGXI |
$10.50 |
+0.08 |
+0.77% |
85,257 |
108% |
$154.0M |
- |
15% |
-30% |
-26.9% |
$7.4M | 523.4K shares - decrease of 62.5K shares
No Alerts/News
|
|
|
| SGMO |
$8.43 |
+0.17 |
+2.06% |
611,291 |
71% |
$451.3M |
- |
109% |
-25% |
+36.6% |
$13.0M | 2.1M shares - decrease of 33.2K shares
No Alerts/News
|
|
|
| SNMX |
$2.09 |
-0.01 |
-0.48% |
21,990 |
13% |
$84.9M |
- |
37% |
-29% |
+9.4% |
$5.2M | 2.8M shares - increase of 817.6K shares
No Alerts/News
|
|
|
| SNSS |
$5.46 |
+0.05 |
+0.92% |
216,330 |
69% |
$281.7M |
- |
137% |
-20% |
-3.9% |
$14.6M | 2.6M shares - New Holding
No Alerts/News
|
|
|
| VNDA |
$6.58 |
+1.08 |
+19.64% |
3,379,397 |
1153% |
$186.5M |
- |
125% |
18% |
+61.7% |
$9.5M | 2.4M shares - decrease of 245.1K shares
1 Alert (0 News) - View
|
|
|
| VSTM |
$9.19 |
-0.25 |
-2.65% |
53,340 |
260% |
$189.6M |
- |
47% |
-23% |
-2.6% |
$5.2M | 557.8K shares - decrease of 47.8K shares
No Alerts/News
|
|
|
|
|
Discuss RA Capital Management's portfolio
|
|
|
|
| |

|
| |
|
| |

|
| |
Derma Sciences Reports First Quarter 2013 Financial Results DSCI
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 16, 07:30AM from (www.businesswire.com) Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported
Flag
Post a comment
ACADIA Pharmaceuticals Prices Public Offering of Common Stock ACAD
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 15, 08:00AM from (www.businesswire.com) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the pricing of an underwritten public offering of 8,000,000 shares
Flag
Post a comment
ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock ACAD
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 14, 04:01PM from (www.businesswire.com) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other
Flag
Post a comment
Jack Green Joins Verastem as Chief Financial Officer VSTM
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 14, 07:00AM from (www.businesswire.com) Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer
Flag
Post a comment
Dyax Announces $30 Million Offering DYAX
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 13, 07:15AM from (www.businesswire.com) Dyax Corp. (NASDAQ: DYAX) announced today that it has priced a registered direct offering with RA Capital Management, Venrock,
Flag
Post a comment
Sunesis to Present at Upcoming Investor Conferences SNSS
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 03:43PM from (globenewswire.com) SOUTH SAN FRANCISCO, Calif., May 10, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced
Flag
Post a comment
Novavax H7N9 VLP Influenza Vaccine Enters Animal Testing NVAX
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 08:13AM from (globenewswire.com)
ROCKVILLE, Md., May 10, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has completed
Flag
Post a comment
Anacor Pharmaceuticals Reports First Quarter 2013 Financial Results ANAC
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 09, 04:01PM from (www.businesswire.com) Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the first quarter ended March 31, 2013. “It
Flag
Post a comment
Sunesis Pharmaceuticals Reports First Quarter Financial Results and Recent Highlights SNSS
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 09, 07:13AM from (globenewswire.com) SOUTH SAN FRANCISCO, Calif., May 9, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial
Flag
Post a comment
ACADIA Pharmaceuticals Reports First Quarter 2013 Financial Results ACAD
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 04:01PM from (www.businesswire.com) ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet
Flag
Post a comment
ArthroCare Reports First Quarter 2013 Financial Results ARTC
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 04:01PM from (www.businesswire.com) ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced
Flag
Post a comment
Derma Sciences to Hold First Quarter Financial Results Conference Call on May 16th DSCI
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 07:30AM from (www.businesswire.com) Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announced
Flag
Post a comment
Insmed Reports First Quarter Financial Results INSM
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 07, 07:30AM from (www2.marketwire.com) Insmed Incorporated (NASDAQ: INSM), ("Insmed" or the "Company"), a biopharmaceutical company focused
Flag
Post a comment
|
|